As of November 2023 Dechra Pharmaceuticals has a market cap of $5.52 Billion. This makes Dechra Pharmaceuticals the world's 2351th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $5.52 B | 53.13% |
2022 | $3.61 B | -53.65% |
2021 | $7.78 B | 53.17% |
2020 | $5.08 B | 30.01% |
2019 | $3.91 B | 45.16% |
2018 | $2.69 B | 2.32% |
2017 | $2.63 B | 71.25% |
2016 | $1.53 B | 7.78% |
2015 | $1.42 B | 24.58% |
2014 | $1.14 B | 13.22% |
2013 | $1.01 B | 19.67% |
2012 | $0.84 B | 58.18% |
2011 | $0.53 B | 4.5% |
2010 | $0.51 B | -2.7% |
2009 | $0.52 B | 48.8% |
2008 | $0.35 B | -8.62% |
2007 | $0.38 B | 42.25% |
2006 | $0.27 B | 17.69% |
2005 | $0.23 B | 29.18% |
2004 | $0.17 B | 57.43% |
2003 | $0.11 B | 55.6% |
2002 | $72.96 M | -30.64% |
2001 | $0.10 B |
On Nov 28th, 2023 the market cap of Dechra Pharmaceuticals was reported to be: